25.03.2013
- AstraZeneca has seen off a remaining threat to its top-selling cholesterol drug Crestor by settling a U.S. legal case with Watson Laboratories, a unit of Actavis, and Egis. The...
18.03.2013
- Thirty years ago, when the world faced the terrifying prospect of an untreatable disease known as AIDS, big drugmakers scented an opportunity and raced to develop new medicines...
18.03.2013
- AstraZeneca is to cut around 1,600 jobs as it overhauls research operations and consolidates drug development work in three major centres in Britain, the United States and Sweden...
18.03.2013
- AstraZeneca's new CEO Pascal Soriot, outlining his investment strategy for the ailing drugmaker this week, is unlikely to offer any quick fixes to plug a looming $6 billion sales...
07.02.2013
- Seven European drugmakers are to pool their research efforts with academic scientists and smaller companies in a new €196 million ($265 million) project designed to find tomorrow's...
31.01.2013
- Business in Great Britain - Since 2008, the UK chemical industry has gone through one of the biggest downturns in production of all the world's leading producers of chemicals. Now...
31.01.2013
- AstraZeneca's new boss warned on Thursday the drugmaker faced a tough year in 2013, with sales expected to fall by a mid-to-high single digit percentage rate as patent expiries...
19.01.2013
- Fighting the flu may soon get easier. As early as next year, more modern and more effective vaccines will hit the market, thanks to investments by the U.S. government and...
